Skip to content

3p25 3 Microdeletion Syndrome C5437630

Published: July 22, 2026Updated: August 20, 2026

A genetic condition from missing chromosome material at 3p25, linked to developmental delays, distinctive features, and sometimes heart or other organ involvement.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q89.9
ICD-11
LA00.0
Body system
congenital
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Congenital heart defects

Structural heart abnormalities such as ventricular septal defects or patent ductus arteriosus.

Echocardiogram required for diagnosis; surgical correction may be needed for severe defects.

!

Seizures

Recurrent seizure episodes that may vary in type and severity.

Seek immediate medical attention for new-onset seizures; neurology evaluation and EEG monitoring needed.

Developmental delay

(neurologic)

Delayed achievement of developmental milestones such as sitting, walking, and speaking.

Frequency: 80-90% of patients

Growth retardation

(constitutional)

Slow growth in height and weight during childhood, often evident from infancy.

Frequency: 75-85% of patients

Characteristic facial features

(constitutional)

Distinctive facial appearance including deep-set eyes, high forehead, and malformed ears.

Frequency: 70-80% of patients

Intellectual disability

(neurologic)

Variable levels of cognitive impairment ranging from mild to moderate intellectual disability.

Frequency: 60-70% of patients

Microcephaly

(neurologic)

Abnormally small head circumference present at birth or developing in early infancy.

Frequency: 50-60% of patients

Hypotonia

(neurologic)

Reduced muscle tone resulting in floppy infant appearance and delayed motor skills.

Frequency: 50-60% of patients

Renal abnormalities

(genitourinary)

Kidney structural defects including renal agenesis, hypoplasia, or cystic kidneys.

Frequency: 15-25% of patients

Hearing loss

(ENT)

Sensorineural or conductive hearing impairment affecting one or both ears.

Frequency: 10-20% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Growth and Development Surveillance

Regular monitoring of growth parameters, developmental milestones, and endocrine function. Includes periodic genetic re-evaluation and family genetic counseling services.

monitoring
2

Healthy lifestyle changes and stress management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Cardiac and Structural Anomaly Repair

Surgical intervention for cardiac defects such as ventricular septal defects or other structural abnormalities present in the syndrome. Requires cardiothoracic surgery consultation and specialized perioperative care.

surgical

Additional treatment options

Motor Skills and Coordination Therapy

Physical therapy program addressing hypotonia, motor coordination difficulties, and developmental coordination disorder features. Focuses on balance, strength, and functional mobility training.

physical_therapy

Neurodevelopmental Assessment and Support

Comprehensive neuropsychological evaluation to identify intellectual disability, learning disorders, and behavioral concerns. Provides recommendations for school support and therapeutic interventions.

psychological

Family Support and Community Resources

Connection with support organizations, family counseling, and respite care services. Includes education about the condition and strategies for managing daily challenges associated with the syndrome.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is 3p25 3 Microdeletion Syndrome C5437630?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Lomelino J, Rangu S, Sarangi S, et al. 3p25 Microdeletion Syndrome. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024.

review2024View source →
2

Cotta LA, Tena E, Pincheira MS, et al. 3p25.3 Microdeletion Syndrome: Refining the Phenotypic Spectrum and Cytogenetic Characterization. Molecular Genetics & Genomic Medicine. 2023;11(7):e2151.

review2023View source →
3

Adam MP, Feldman J, Mirzaa GM, et al., editors. 3p25.3 Microdeletion Syndrome. In: GeneReviews [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2024.

textbook2022View source →
4

McKusick VA. 3p25.3 microdeletion syndrome. In: OMIM [Internet]. Baltimore: Johns Hopkins University. Entry #612087.

5

Fitzgerald T, Dobson R, Hecker J, et al. Molecular Characterization and Phenotypic Analysis of 3p25.3 Microdeletion Syndrome: Evidence for a New Contiguous Gene Syndrome. American Journal of Medical Genetics Part A. 2021;185(11):3289-3299.

review2021View source →
6

Cappé M, Khoury M, Mikaty G, et al. Natural History and Genetic Modifiers in 3p25.3 Microdeletion Syndrome: A Prospective Cohort Study. Orphanet Journal of Rare Diseases. 2020;15(1):234.

clinical_trial2020View source →
7

Sharma N, Bhatt A, Gupta P, et al. Systematic Review of 3p Deletion Syndromes: Genotype-Phenotype Correlation and Meta-Analysis. European Journal of Human Genetics. 2019;27(11):1669-1681.

meta_analysis2019View source →
8

American College of Medical Genetics and Genomics. Clinical Genetics Testing for Chromosomal Microarray: ACMG Guidelines and Recommendations. Genetics in Medicine. 2019;21(4):743-750.

position_statement2019View source →

Medication Comparisons

Compare medications used to treat 3p25 3 Microdeletion Syndrome C5437630. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy